ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions.
about
ALK Signaling and Target Therapy in Anaplastic Large Cell LymphomaAnaplastic lymphoma kinase-positive large B-cell lymphoma: an underrecognized aggressive lymphomaAnaplastic lymphoma kinase-positive diffuse large B-cell lymphoma presenting in nasal cavity: a case report and review of literaturePromising response of anaplastic lymphoma kinase-positive large B-cell lymphoma to crizotinib salvage treatment: case report and review of literatureAnaplastic lymphoma kinase-positive large B-cell lymphoma: Clinico-pathological study of 17 cases with review of literature.KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue onlyALK-driven tumors and targeted therapy: focus on crizotinibPrevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitorsALK-immunoreactive neoplasms.SEC31A-ALK Fusion Gene in Lung Adenocarcinoma.PCM1-JAK2-fusion: a potential treatment target in myelodysplastic-myeloproliferative and other hemato-lymphoid neoplasms.The emerging role of ALK inhibitors in the treatment of advanced non-small cell lung cancer.ALK-mutated non-small-cell lung cancer: a new strategy for cancer treatment.ALK-positive cancer: still a growing entity.Novel ALK inhibitors in clinical use and development.A Novel Non-Immunoglobulin (non-Ig)/BCL6 Translocation in Diffuse Large B-Cell Lymphoma Involving Chromosome 10q11.21 Loci and Review on Clinical Consequences of BCL6 Rearrangements.CD20-negative diffuse large B cell lymphoma: a comprehensive analysis of 695 cases.ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern.Anaplastic lymphoma kinase positive large B-cell lymphoma: Literature review and report of an endoscopic fine needle aspiration case with tigroid backgrounds mimicking seminoma.Targeting ALK: Precision Medicine Takes on Drug Resistance.NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases.Cytogenetically complex SEC31A-ALK fusions are recurrent in ALK-positive large B-cell lymphomasIdentification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma.WD40 repeat domain proteins: a novel target class?ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements.Anchored multiplex PCR for targeted next-generation sequencing reveals recurrent and novel USP6 fusions and upregulation of USP6 expression in aneurysmal bone cyst.A case of anaplastic lymphoma kinase-positive large B-cell lymphoma: aspiration cytology findings.Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes.Identification of RANBP2-ALK fusion in ALK positive diffuse large B-cell lymphoma.Plasmacytic ALK-positive large B-cell lymphoma: a potential mimic of extramedullary plasmacytoma.
P2860
Q21129306-D88A31A8-BD42-4B55-9EBC-2082053AB799Q21285042-13B73FE8-1A55-49ED-B40E-5E3B0E81296FQ26862702-DA9780E9-51BC-4A5E-ACDD-FC8B0FD64C12Q27853192-E41DC2A1-B4A8-409F-8643-187AF56DB0BBQ33859852-19CA87B1-B926-4DB5-B3AE-F7D907F54B89Q34162787-7C915CC7-AC1F-4EA6-B330-2FBE91ACADECQ34414378-3DE2D646-849C-44EF-8231-BC4030CF7B0EQ34564071-3F8BC9FF-BC3F-421E-A3B0-D4FCFAC1C722Q36092957-C6582EF7-228F-43DE-95A3-03B70BA7A6BCQ36482476-9DBC0616-8AAF-4F39-B5C6-AC2BEA023CDFQ37810947-238C697E-19F2-43DF-8BD3-925267F00015Q37996424-5C017EED-1B0E-4A46-BED0-BE413587B0ADQ38010052-3CE1DB56-10E4-4B6A-94DD-999A60E2701FQ38184584-E2C9B07F-B20C-45ED-9126-80BB600F8BCAQ38427240-DC0359D6-7C91-4605-AEE3-ED761B739A85Q38576194-72B53389-97D8-4362-A72F-4A832B6D020DQ38605346-DD87CB76-B2D5-4BEA-980B-F2A713A5E8F6Q38701797-69BAD9BC-BED8-4C62-A896-ACB217E7A39FQ38968118-8CDCAFCE-49A2-49B4-935B-97451593A47BQ39103431-0B583AE7-B228-4251-8ECA-D7ED8F961015Q42254184-C797D1FC-0ACF-4157-B4DC-2DB4EC3C2EA2Q42586803-02791ADE-C512-4A61-A004-0970949343B5Q42639021-7846251A-B1AD-4B91-B11F-B19C1C744F72Q47291150-EFA44EE9-DB84-4814-B161-C0D2CAC7FFEDQ51061497-0CDFDCA6-C1B0-4EFB-91EB-7A0E68AEB853Q51290543-7019935E-5675-4C37-B45E-DF8D444B226AQ51827463-5DA52D07-C372-49E8-9DB3-B83EA6626567Q52679023-4A985E4D-7857-4288-9156-E8C67520E117Q54225770-7EBC8BBF-011C-4F7C-9D7B-DA66174F9898Q54342273-5E07A38F-0DD9-4ACD-8F42-A1D6A480B41C
P2860
ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions.
@ast
ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions.
@en
type
label
ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions.
@ast
ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions.
@en
prefLabel
ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions.
@ast
ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions.
@en
P2093
P2860
P50
P1433
P1476
ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions.
@en
P2093
Chris De Wolf-Peeters
José Thomas
Katrien Van Roosbroeck
Michel Stul
Peter Marynen
P2860
P304
P356
10.3324/HAEMATOL.2009.014761
P577
2010-03-01T00:00:00Z